Stem Cell Research · 2020 · 13 citations · 0 references
Life SciencesGeneticsMolecular GeneticsGene TherapyGenome EditingMedical GeneticsCystic FibrosisEmbryonic Stem CellsGenetic DisordersMutation ScreeningPluripotent Stem CellsTherapeutic Genome EditingCftr Gene MutationsCystic Fibrosis GeneticsDisease ModellingDrug ScreeningInduced PluripotencyInduced Pluripotent Stem Cell ReprogrammingInduced Pluripotent Stem CellsPluripotency
Skin fibroblasts obtained from a 27-year-old man with clinically manifested and genetically proven (F508del/F508del) cystic fibrosis were successfully transformed into induced pluripotent stem cells (iPSCs) by using Sendai virus-based reprogramming vectors including the four Yamanaka factors, OCT3/4, SOX2, KLF4, and c-MYC. The iPSCs showed a normal karyotype, expressed pluripotency markers and exhibited the potential to differentiate into three germ layers in spontaneous differentiation assay. This iPSC line may be subsequently used for development of a personalized etiotropic treatment including genome editing, and for disease modelling and drug screening.